Lindahl advised Swedencare on the deal.
Swedencare announced a share issue of 11,954,200 shares, corresponding to approximately 1,150 MSEK. The shares in the directed cash share issue is subscribed for in equal parts by the German listed company Symrise AG and a Swedish financial investor. The proceeds raised by Swedencare in the cash share cash issue will be used to partially finance the acquisition of the Vetio Group. Symrise AG is a leading actor in taste development for the global animal feed market and will after the share issue have an ownership of approximately five percent of the shares in Swedencare. Swedencare’s intention is to, with Symrise AG as a strategic owner, be able to accelerate its business, primarily in animal feed collaborations, and, with the new financial investor, gain access to a global network and expertise in M&A and business development.
Swedencare develops, produces, markets and sells premium products in the global and fast-growing market for animal health products for cats, dogs and horses. Swedencare’s product groups are represented on approximately fifty markets around the world and are sold through subsidiaries in the Nordics, United States, France, Spain, Greece, Great Britain and Ireland, and through an external distribution network. Swedencare’s shares are listed on Nasdaq First North Growth Market. Through the acquisition of the Vetio Group, Swedencare gains a strong position in the manufacture and development of premium brands for the animal health market in the US and Canada.
Lindahl’s team consisted of Johan Herrström (Picture), Annika Brandt, Henrik Nilsson, Victoria Volny, Christian Sundén, Jesper Fredriksson, Johanna Svensson, André Persson and Pontus Söderberg.
Involved fees earner: Annika Brandt – Lindahl; Jesper Fredriksson – Lindahl; Johan Herrström – Lindahl; André Persson – Lindahl; Pontus Söderberg – Lindahl; Christian Sundén – Lindahl; Johanna Svensson – Lindahl;
Law Firms: Lindahl;
Clients: Swedencare AB ;